80 related articles for article (PubMed ID: 17805056)
1. HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas.
Inamura K; Togashi Y; Okui M; Ninomiya H; Hiramatsu M; Satoh Y; Okumura S; Nakagawa K; Shimoji T; Noda T; Ishikawa Y
J Thorac Oncol; 2007 Sep; 2(9):802-7. PubMed ID: 17805056
[TBL] [Abstract][Full Text] [Related]
2. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer susceptibility genetic variants modulate HOXB2 expression in the lung.
Clemenceau A; Boucherat O; Landry-Truchon K; Lamontagne M; Biardel S; Joubert P; Gobeil S; Secco B; Laplante M; Morissette M; Obeidat M; Timens W; Jeannotte L; Bossé Y
Int J Dev Biol; 2018; 62(11-12):857-864. PubMed ID: 30604855
[TBL] [Abstract][Full Text] [Related]
4. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia.
Segara D; Biankin AV; Kench JG; Langusch CC; Dawson AC; Skalicky DA; Gotley DC; Coleman MJ; Sutherland RL; Henshall SM
Clin Cancer Res; 2005 May; 11(9):3587-96. PubMed ID: 15867264
[TBL] [Abstract][Full Text] [Related]
5. Thyroid transcription factor-1 amplification and expressions in lung adenocarcinoma tissues and pleural effusions predict patient survival and prognosis.
Li X; Wan L; Shen H; Geng J; Nie J; Wang G; Jia N; Dai M; Bai X
J Thorac Oncol; 2012 Jan; 7(1):76-84. PubMed ID: 22011671
[TBL] [Abstract][Full Text] [Related]
6. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
7. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
[TBL] [Abstract][Full Text] [Related]
8. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
9. Nanog, a novel prognostic marker for lung cancer.
Du Y; Ma C; Wang Z; Liu Z; Liu H; Wang T
Surg Oncol; 2013 Dec; 22(4):224-9. PubMed ID: 24018162
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients.
Pan YQ; Zhang X; Xu DP; Bao WG; Lin AF; Xu HH; Yan WH
Neoplasma; 2014; 61(4):468-75. PubMed ID: 24712846
[TBL] [Abstract][Full Text] [Related]
11. High expression of homeobox B2 predicts poor survival of colon adenocarcinoma by enhancing tumor proliferation and invasion.
Li S; Wang Y; Xuan Z; Zhang Y; Miao Z
Ir J Med Sci; 2023 Feb; 192(1):89-97. PubMed ID: 35320486
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
Guo L; Wang J; Yang P; Lu Q; Zhang T; Yang Y
IUBMB Life; 2015 Sep; 67(9):720-5. PubMed ID: 26314828
[TBL] [Abstract][Full Text] [Related]
13. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
[TBL] [Abstract][Full Text] [Related]
15. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
[TBL] [Abstract][Full Text] [Related]
16. Effect of human cytomegalovirus infection on the expression of Hoxb2 and Hoxb4 genes in the developmental process of cord blood erythroid progenitors.
Liu WJ; Huang MX; Guo QL; Chen JH; Shi H
Mol Med Rep; 2011; 4(6):1307-11. PubMed ID: 21879259
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological significance of homeobox BP1 mRNA expression in lung cancer tissue].
Xian YS; Dang CX; Yan CX; Li HP; Fu SW; Wang ZR
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1173-5. PubMed ID: 16939914
[TBL] [Abstract][Full Text] [Related]
19. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
[TBL] [Abstract][Full Text] [Related]
20. DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.
Zhu J; Wu C; Li H; Yuan Y; Wang X; Zhao T; Xu J
Tumour Biol; 2016 Jul; 37(7):9781-8. PubMed ID: 26810067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
